id: NEW:alcohol_associated_liver_disease_to_liver_disease_mortality
name: Alcohol-Associated Liver Disease â†’ Liver Disease Mortality
from_node:
  node_id: NEW:alcohol_associated_liver_disease
  node_name: Alcohol-Associated Liver Disease
to_node:
  node_id: liver_disease_mortality
  node_name: Liver Disease Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Alcohol-associated liver disease progresses through stages of fatty liver, steatohepatitis,
  fibrosis'
- 'Step 2: Advanced liver disease leads to portal hypertension and synthetic dysfunction'
- 'Step 3: Complications including variceal bleeding, hepatic encephalopathy, and hepatorenal syndrome
  develop'
- 'Step 4: End-stage liver disease results in premature mortality without transplantation'
evidence:
  quality_rating: A
  n_studies: 35
  primary_citation: 'Sachin Amonker et al. 2023. "Prevalence of alcohol-associated liver disease: a systematic
    review and meta-analysis." https://doi.org/10.1097/HC9.0000000000000133'
  supporting_citations:
  - Additional citations require full-text access
  - Meta-analysis notes ALD is 'a common cause of morbidity and premature mortality'
  - 35 studies synthesized representing the first systematic synthesis of ALD prevalence
  doi: 10.1097/HC9.0000000000000133
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The abstract explicitly identifies alcohol-associated liver disease as 'a common cause of
  morbidity and premature mortality,' establishing the pathway from ALD to early death. The high prevalence
  of ALD and cirrhosis in AUD populations represents a significant source of preventable mortality.
quantitative_effects:
  sample_size: 513278
structural_competency:
  equity_implications: Premature mortality from ALD reflects cumulative structural failures in alcohol
    policy (pricing, availability, marketing), healthcare access (screening, treatment for AUD), and social
    determinants that drive problematic alcohol use. The authors' conclusion that 'targeted interventions
    for liver disease such as case finding will be more effective in at-risk populations' points to structural
    healthcare system changes needed to prevent mortality.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.420574'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
